- Home
- LRE vs POM Comparison
LRE vs POM Comparison
Compare LRE & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LRE | POM |
|---|---|---|
| Founded | 2001 | 2015 |
| Country | Japan | China |
| Employees | N/A | 165 |
| Industry | | Other Specialty Stores |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.8M | 13.6M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | LRE | POM |
|---|---|---|
| Price | $1.31 | $1.48 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 12.7K | ★ 980.4K |
| Earning Date | 07-30-2015 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.16 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $0.06 |
| 52 Week High | $2.86 | $6.43 |
Technical Indicators
Market Signals| Indicator | LRE | POM |
|---|---|---|
| Relative Strength Index (RSI) | 53.60 | 88.97 |
| Support Level | $1.17 | $0.17 |
| Resistance Level | $1.37 | $5.00 |
| Average True Range (ATR) | 0.07 | 0.08 |
| MACD | -0.00 | 0.17 |
| Stochastic Oscillator | 78.57 | 100.00 |
Price Performance
Historical ComparisonAbout LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa Prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment units to individual customers in Japan and Dallas, Texas. Its revenue is predominantly generated from developing and selling single-family homes and condominiums, hotel operations, and residential leasing. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.
About POM POMDOCTOR LIMITED American Depositary Shares
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of its revenue is derived from the Pharmaceutical supply chain segment.